Artificial Intelligence in Medicine

Brain age model performs more reliably on outside datasets

Tests across multiple large brain-imaging cohorts found that learned reference maps supported age predictions comparable to leading models and greater robustness on outside datasets.

Paper by Clara Lisazo, Adrià Casamitjana, Arnau Oliver, Xavier Lladó · Universitat de Girona
Graphical abstract from Artificial Intelligence in Medicine
Open the figure at full size
Graphical abstract. Lisazo et al.

Our read

Biomarkers
Studied:
Computational study of people, against state-of-the-art convolutional models
What changed:
The model improved robustness under distribution shift in external datasets compared with state-of-the-art convolutional models
The catch:
Did not measure whether the model improves diagnosis in clinical practice
Why it’s aging research:
It builds or tests a tool for aging research.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Researchers tested a computational model using structural magnetic resonance imaging scans from people in multiple large brain-imaging cohorts. Rather than selecting individual scans as references, the model learned age-specific patterns and converted them into reference brain maps.

Its brain age predictions were comparable to those of leading models on data similar to its training data. It performed more robustly on outside datasets. Differences between scans and age-matched references also improved the distinction between healthy people and people with Alzheimer’s disease, beyond the gap between predicted and actual age. The learned maps followed smoother, more biologically consistent aging patterns than references selected from real scans.

Why it matters

For Alzheimer’s disease, the work addresses whether departures from typical brain aging could provide useful diagnostic information beyond an estimated brain age.

Caveats

These were computational tests, not evidence that the model improves diagnosis in clinical practice. The abstract does not report cohort sizes or numerical measures of prediction accuracy or disease discrimination.

Comments

Be the first to comment.